Dear Editor, With the advent of COVID-19 globally, many doctors have begun to review the medications that are already available to treat and/or protect against the infection. One of these drugs is the antiparasitic ivermectin. The first clinical trial was registered by Zagazig University in May, 2020; and hence, it has been adopted in several studies.